Atlas Trials

Selective Intra-arterial Injection of PRRT in Neuroendocrine Tumor Patients With Liver Metastases

Clinical trial NCT03724409 · TERMINATED

Trial details

NCT number
NCT03724409
Sponsor
Sandeep Laroia
Status
TERMINATED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2018-10-11
Primary completion
2021-03-21
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.